Missy Krasner, Executive in Residence, and Matthew Holt Co-Founder of Health 2.0 opens the DC to VC event followed by the interview of Jeff Tangney, CEO and Founder of Doximity and Epocrates moderated by Rebecca Lynn, Partner at Morgenthaler Ventures. Then, there are financial presentations for Health IT by Partners from a variety of Venture Capital firms and a panel consisting of the Director of the ONC, HIT and the officials who are at the forefront of Health Care today.
Andrew is responsible for providing strategic insight to Dell’s healthcare solutions. Today Andrew is going to talk about Dell’s project with the Traslational Genomics Institute which analyzes the genome of children with neuroblastoma to find the best matching cancer drug.
The tools, devices, sensors and other technologies that will be used to collect and monitor health data and customize it to the user. Going forward, how will genomics, robotics and behavior change fit into personalized health?